Other
Neoplasm by Site
CI-CAN-00000003Explore in graph →
Non-malignant20,504 active trials253 approved drugs3,568 evidence items
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000003Explore in graph →
Clinical trials
92,622 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05613738 | 177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate Cancer | unknown | N/A | 9 | Peking Union Medical College HospitalOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT05618990 | OPTIMIZATION of ADVANCED MR SEQUENCES(OPT-IRM) | unknown | — | 300 | Centre Hospitalier St AnneOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT06362980 | A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations(EGFR) | unknown | Phase 1 | 20 | National Cancer Center, ChinaOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT06387810 | Irinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic Cancer(undetermined) | unknown | Phase 2 | 45 | Peking Union Medical College HospitalOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT06494800 | Added Value of PET/CT in Lung Cancer | unknown | — | 30 | Sohag UniversityOTHER | 0 | Jul 10, 2024 | clinicaltrials |
| NCT06495034 | Airwave Compression Therapy to Prevent Breast Cancer-related Lymphedema | unknown | N/A | 132 | Shantou Central HospitalOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT04197856 | Direct Information to At-risk Relatives(DIRECT) | unknown | N/A | 490 | Umeå UniversityOTHER | 1 | Jul 9, 2024 | clinicaltrials |
| NCT04266223 | Surface Monitoring Technology to Remove The Mask - Stage 1(SMART) | unknown | N/A | 20 | University of SydneyOTHER | 1 | Jul 9, 2024 | clinicaltrials |
| NCT04715633 | PD-1 Inhibitors Combined With VEGF Inhibitors for Locally Advanced dMMR/MSI-H Colorectal Cancer | unknown | Phase 2 | 53 | Sun Yat-sen UniversityOTHER | 1 | Jul 9, 2024 | clinicaltrials |
| NCT05739045 | Nivolumab Combined With SOX Used in the Perioperative Treatment | unknown | Phase 2 | 46 | Xiangdong ChengOTHER | 1 | Jul 9, 2024 | clinicaltrials |
| NCT06491355 | First-Line Treatment Induced With mFOLFOX6 and HLX04 Regimen, Following Combined With Serplulimab in MSS Initially Unresectable Metastatic Colorectal Cancer | unknown | Phase 2 | 72 | Sir Run Run Shaw HospitalOTHER | 1 | Jul 9, 2024 | clinicaltrials |
| NCT06492629 | Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma | unknown | Phase 2 | 43 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jul 9, 2024 | clinicaltrials |
| NCT02355379 | Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over(ADAGE) | unknown | Phase 3 | 774 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT03760822 | Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients(SOCRATE) | unknown | Phase 2 | 112 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT03959293 | Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma | unknown | Phase 2 | 107 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT04862078 | Shared Decision Making in Surveillance for Distant Metastasis in Breast Cancer(SMART-FU) | unknown | N/A | 368 | Seoul National University HospitalOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT04891900 | TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma | unknown | N/A | 25 | Henan Cancer HospitalOTHER_GOV | 1 | Jul 8, 2024 | clinicaltrials |
| NCT05244213 | Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLC(NEOTIDE) | unknown | Phase 2 | 35 | Guangdong Provincial People's HospitalOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT06355037 | Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer | unknown | Phase 2 | 10 | Fudan UniversityOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT06476964 | Stratification of Cutaneous Squamous Cell Carcinomas According to Its Transcriptomic, Metabolic and Inflammatory Characteristics(StratiKA) | unknown | N/A | 200 | University Hospital, BordeauxOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT04535713 | GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma | unknown | Phase 2 | 260 | Sarcoma Oncology Research Center, LLCOTHER | 1 | Jul 5, 2024 | clinicaltrials |
| NCT05543954 | 68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients | unknown | Early Phase 1 | 60 | Peking Union Medical College HospitalOTHER | 1 | Jul 5, 2024 | clinicaltrials |
| NCT06488391 | The Impact of Respiratory Training of DIBH Radiotherapy for Breast Cancer | unknown | N/A | 80 | Jianjun LaiOTHER | 1 | Jul 5, 2024 | clinicaltrials |
| NCT06489184 | The Real World Study of Zanubrutinib in the Treatment of Chronic Lymphocytic Leukemia in China | unknown | — | 490 | Peking University People's HospitalOTHER | 1 | Jul 5, 2024 | clinicaltrials |
| NCT06489288 | ERAS in Totally Laparoscopic Total Gastrectomy for Gastric Cancer | unknown | N/A | 2,656 | Xijing HospitalOTHER | 1 | Jul 5, 2024 | clinicaltrials |
| NCT01638130 | Experiences and Needs of Patients With a High-grade Glioma and Their Caregivers | unknown | — | 30 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03079323 | Trial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate Cancer(PART) | unknown | Phase 2 | 137 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03080116 | Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy(ARNEO) | unknown | Phase 2 | 90 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03327675 | High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate Cancer | unknown | N/A | 188 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03340376 | Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer | unknown | Phase 2 | 48 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03784066 | Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity(DUTRELASCO) | unknown | Phase 1 / Phase 2 | 21 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03819751 | MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection(PROSOVI) | unknown | N/A | 96 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03885648 | Breast Cancer and Its Relationship With the Microbiota(MICROMA) | unknown | — | 150 | Universidad de GranadaOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT04562337 | SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC | unknown | Phase 2 | 67 | Shandong Cancer Hospital and InstituteOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT04654975 | Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)(METABREC) | unknown | — | 10,000 | Universitaire Ziekenhuizen KU LeuvenOTHER | 6 | Jul 3, 2024 | clinicaltrials |
| NCT04990076 | Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology(MUSA1) | unknown | — | 1,500 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05229003 | Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC | unknown | Phase 2 | 44 | Fudan UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05610501 | Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses. | unknown | — | 200 | Universitaire Ziekenhuizen KU LeuvenOTHER | 4 | Jul 3, 2024 | clinicaltrials |
| NCT05797454 | Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer | unknown | N/A | 170 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05838001 | Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer After Neoadjuvant Therapy | unknown | N/A | 110 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05847348 | 68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients | unknown | Phase 3 | 110 | Telix Pharmaceuticals (Innovations) Pty LimitedINDUSTRY | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06090656 | Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermediate Stage Hepatocellular Carcinoma (Beyond Up-To-Seven Criteria)(BEST) | unknown | Phase 2 | 88 | Sun Yat-sen UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06482281 | COVID-19 and Childhood Cancer | unknown | — | 100,000 | Karolinska InstitutetOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06483919 | The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer | unknown | — | 228 | Jinming YuOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06484361 | PET/MRI to Stage Prostate Cancer Patients | unknown | Phase 2 | 50 | IRCCS San RaffaeleOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06485557 | A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC | unknown | Phase 3 | 90 | Tang-Du HospitalOTHER | 0 | Jul 3, 2024 | clinicaltrials |
| NCT06485713 | Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC | unknown | Phase 2 | 200 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06486220 | PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial. | unknown | Phase 3 | 96 | Yun-fei XiaOTHER | 0 | Jul 3, 2024 | clinicaltrials |
Data updated 24 days agoSource updated Jul 10, 2024source: clinicaltrials